LTBP3
Basic information
Region (hg38): 11:65538559-65558930
Previous symbols: [ "LTBP2" ]
Links
Phenotypes
GenCC
Source:
- brachyolmia-amelogenesis imperfecta syndrome (Definitive), mode of inheritance: AR
- geleophysic dysplasia 3 (Limited), mode of inheritance: AD
- brachyolmia-amelogenesis imperfecta syndrome (Limited), mode of inheritance: AR
- Acromicric dysplasia (Supportive), mode of inheritance: AD
- geleophysic dysplasia (Supportive), mode of inheritance: AD
- brachyolmia-amelogenesis imperfecta syndrome (Supportive), mode of inheritance: AR
- brachyolmia-amelogenesis imperfecta syndrome (Strong), mode of inheritance: AR
- geleophysic dysplasia 3 (Strong), mode of inheritance: AD
Clinical Genomic Database
Source:
Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
---|---|---|---|---|---|
Geleophysic dysplasia 3; Dental anomalies and short stature | AD/AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Dental; Musculoskeletal | 19344874; 25669657; 25899461; 27068007 |
ClinVar
This is a list of variants' phenotypes submitted to
- Brachyolmia-amelogenesis_imperfecta_syndrome (1315 variants)
- Inborn_genetic_diseases (794 variants)
- not_provided (77 variants)
- LTBP3-related_disorder (58 variants)
- Geleophysic_dysplasia_3 (19 variants)
- not_specified (7 variants)
- Heritable_Thoracic_Aortic_Disease (3 variants)
- Amelogenesis_imperfecta (1 variants)
- Intellectual_disability (1 variants)
- Geleophysic_dysplasia (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the LTBP3 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001130144.3. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
---|---|---|---|---|---|---|
synonymous | 17 | 486 | 508 | |||
missense | 792 | 21 | 818 | |||
nonsense | 10 | 16 | ||||
start loss | 0 | |||||
frameshift | 35 | 47 | ||||
splice donor/acceptor (+/-2bp) | 22 | 26 | ||||
Total | 50 | 35 | 818 | 507 | 5 |
Highest pathogenic variant AF is 0.000236678
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
LTBP3 | protein_coding | protein_coding | ENST00000301873 | 28 | 20126 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.686 | 0.314 | 125708 | 0 | 40 | 125748 | 0.000159 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 2.85 | 553 | 776 | 0.712 | 0.0000489 | 8339 |
Missense in Polyphen | 162 | 287.77 | 0.56294 | 3044 | ||
Synonymous | 0.892 | 316 | 337 | 0.938 | 0.0000239 | 2553 |
Loss of Function | 5.89 | 14 | 65.4 | 0.214 | 0.00000303 | 743 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.000188 | 0.000181 |
Ashkenazi Jewish | 0.000104 | 0.0000992 |
East Asian | 0.000170 | 0.000163 |
Finnish | 0.000275 | 0.000231 |
European (Non-Finnish) | 0.000216 | 0.000211 |
Middle Eastern | 0.000170 | 0.000163 |
South Asian | 0.0000681 | 0.0000653 |
Other | 0.000168 | 0.000163 |
dbNSFP
Source:
- Function
- FUNCTION: Key regulator of transforming growth factor beta (TGFB1, TGFB2 and TGFB3) that controls TGF-beta activation by maintaining it in a latent state during storage in extracellular space. Associates specifically via disulfide bonds with the Latency- associated peptide (LAP), which is the regulatory chain of TGF- beta, and regulates integrin-dependent activation of TGF-beta. {ECO:0000303|PubMed:10743502, ECO:0000303|PubMed:11104663}.;
- Disease
- DISEASE: Dental anomalies and short stature (DASS) [MIM:601216]: A disorder characterized by hypoplastic amelogenesis imperfecta, significant short stature, brachyolmia-like anomalies including platyspondyly with short pedicles, narrow intervertebral and interpedicular distances, rectangular-shaped vertebrae with posterior scalloping and herniation of the nuclei, and broad femoral necks. Dental anomalies include widely spaced, small, yellow teeth, oligodontia, and severely reduced to absent enamel. {ECO:0000269|PubMed:19344874}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Geleophysic dysplasia 3 (GPHYSD3) [MIM:617809]: A form of geleophysic dysplasia, a rare skeletal disease characterized by severe short stature, short hands and feet, and joint limitations. Radiologic features include delayed bone age, cone-shaped epiphyses, shortened long tubular bones, and ovoid vertebral bodies. Affected individuals have characteristic facial features including a 'happy' face with full cheeks, shortened nose, hypertelorism, long and flat philtrum, and thin upper lip. Other distinctive features include skin thickening, progressive cardiac valvular thickening often leading to an early death, toe walking, tracheal stenosis, respiratory insufficiency, and lysosomal-like storage vacuoles in various tissues. GPHYSD3 inheritance is autosomal dominant. {ECO:0000269|PubMed:27068007}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Extracellular matrix organization;Molecules associated with elastic fibres;Elastic fibre formation
(Consensus)
Recessive Scores
- pRec
- 0.128
Intolerance Scores
- loftool
- 0.0559
- rvis_EVS
- -0.93
- rvis_percentile_EVS
- 9.61
Haploinsufficiency Scores
- pHI
- 0.304
- hipred
- Y
- hipred_score
- 0.655
- ghis
- 0.677
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.646
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Ltbp3
- Phenotype
- vision/eye phenotype; skeleton phenotype; immune system phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); respiratory system phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); growth/size/body region phenotype; craniofacial phenotype;
Zebrafish Information Network
- Gene name
- ltbp3
- Affected structure
- pharyngeal vasculature
- Phenotype tag
- abnormal
- Phenotype quality
- malformed
Gene ontology
- Biological process
- transforming growth factor beta activation;positive regulation of mesenchymal stem cell proliferation;positive regulation of mesenchymal stem cell differentiation
- Cellular component
- extracellular region;collagen-containing extracellular matrix;extracellular exosome
- Molecular function
- calcium ion binding;transforming growth factor beta binding